11 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: American Academy for Cerebral Palsy and Developmental Medicine Transformative Practice Award
The AACPDM is pleased to announce the introduction of a new award designed to facilitate sharing of expertise among members of the Academy. The Transformative Practice Award will provide financial support for collaboration among members for the purpose of implementing an evidence-based management strategy in clinical practice. One award of up to $4000.00 will be available for 2014. The application deadline is February 28, 2014.
The intent of the Transformative Practice Award is to facilitate the translation of evidence based clinical management strategies into practice. Funding is available to support members to plan and implement specific intervention strategies that are supported by research evidence. The award is based on the premise of ‘academic detailing’ whereby ‘experts’ who have been involved in the successful implementation of specific evidence-based management strategies within their facility support the host facility in the implementation of those strategies for changing clinical practice. Research suggests that academic detailing is an effective strategy for implementing changes in clinical practice. The specific objectives of the program are to:
Facilitate sharing of expertise and knowledge regarding implementation of specific, evidence-based, clinical management strategies into practice among AACPDM members.
Ensure that implementation of new clinical management strategies is based on established practices such as addressing local barriers to implementation and the involvement of relevant stakeholders in planning.
Assist the development of implementation plans and evaluation plans for determining how successful the initiative was in changing clinical practice.
Applicants and identified experts must be current AACPDM members.
Applicants must not have received an AACPDM Transformative Practice Grant within the past five years.
Proposed management strategies for implementation must be relevant for individuals with cerebral palsy, developmental disorders, or other childhood acquired disability.
TERMS OF AWARD
AACPDM members are invited to submit applications describing planned implementation of management strategies for populations included in the mandate of the AACPDM. Potential activities for translation of management strategies into practice include but are not limited to:
On-site feedback from an expert in the relevant clinical area who has demonstrated success with implementation of the management strategy
Meetings with relevant, key stakeholders to identify and overcome local barriers to implementation.
Follow-up meeting(s) or teleconferences with the expert to allow for ongoing support and guidance.
Evaluation of implementation of strategies related to practice change (i.e., how did practice change after implementation of activities outlined in this application?)
Activities related to the transformative practice award must be completed within one year of receipt of the award. The grant amount is up to $4000.00 per award. In 2014, one award will be granted to members living within North America. Following the first year, the award will be evaluated and plans will be reviewed to allow for international member applications. A final report will be required within 3 months of the end of the term of the award. The final report must include a description of activities, the results of the evaluation of implementation and a line-by-line description of how funds were spent.
Eligible expenses include:
Travel expenses for the expert
On-site meeting related expenses
Knowledge translation activity expenses
Personal remuneration, administrative costs (i.e., standard office equipment and supplies), and activities unrelated to the implementation of the management strategy outlined in the proposal are ineligible expenses.
Call for Applications: Grant for Multiple Sclerosis Innovation
The deadline for grant applications is 28 February 2014.
The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of MS for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programmes, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.
A total grant of up to €1,000,000 will be awarded to one or more selected projects. The grant will build on the success of the Grant for Fertility Innovation (GFI), which has awarded grants that total up to €6,000,000 to translational research projects since 2010.
Applications are invited from around the world and will be reviewed by the Scientific Committee against the following criteria:
Relevance to clinical practice
For further information on the GMSI and to register your interest in applying for the GMSI 2014, please contact: email@example.com
Parkinson’s Disease Foundation-Parkinson Study Group Mentored Clinical Research Award
The Mentored Clinical Research Award (MCRA) for new investigators is funded by a grant from the Parkinson’s Disease Foundation (PDF) to the Parkinson Study Group (PSG). The grant supports new investigators for a one-year project in patient-oriented research in Parkinson’s disease or other parkinsonian disorders under the mentorship of an experienced investigator. The goal of the award is to provide funding for an investigator who has the potential to become an independent researcher.
It is anticipated for the current application period that an award of $50,000 will be available. Only direct costs will be funded by this award.
Eligibility & Restrictions
Applicants for the MCRA should be clinicians and scientists who are within five years of having completed formal training. Fellows may apply. If during formal training unusual circumstances occurred to delay completion, “time out” periods will be permitted and should be explained in the application cover letter.
Applicants must identify an appropriate mentor or mentors with extensive research experience. Either the applicant or the mentor must be a member of the PSG. An applicant may have co-mentors.
Proposals for the MCRA are due on Friday, January 3, 2014, to be considered for funding. Please note that this is a collaborative fellowship and for this program, applicants cannot use PDF's online grant management system. Instead, applicants should submit an electronic copy of the proposal in Microsoft Word of .pdf format to the PSG to Roseanna.Battista@ctcc.rochester.edu with a cover note that includes the candidate’s name and the title of proposal.
Proposals should be hypothesis driven and amenable to completion in a one year time period. The proposal should be directed toward patient oriented research in Parkinson’s disease or related parkinsonian disorders.
All applications for this fellowship should include the following elements:
The focus of the proposal must relate to an area of importance in the field. The research plan should address unmet needs of people living with PD, have the potential for broad application among the PD community, and lead to advances in clinically relevant treatment options;
A research proposal (five pages in length) including an abstract, specific aims, background and significance, preliminary studies and experimental designs and methods;
A clear description of the educational plan that will be implemented to educate the candidate in development of appropriate research methodology under the direction of the mentor;
A statement of the qualification of the mentor(s) to guide the research program.
An electronic copy of the proposal in Microsoft Word or pdf-format;
The candidate’s proposal should be formatted according to the guidelines indicated on the PSG website.
The research plan itself should not exceed five pages. The candidate should also include a four-page NIH-style biosketch and other support statement for both the applicant and the mentor(s);
The proposal should include a statement from the mentor(s) including information on research qualifications.
The statement should include the nature of the supervision that will occur during the award period and an agreement to provide mentorship to the candidate for the award period. The mentor must include information on what skills they plan to teach the mentee and how previous fellows they mentored are contributing to Parkinson’s research (if applicable);
A budget and brief budget justification are required for all funds requested. No indirect costs will be funded;
The funding request should not exceed $50,000;
Clinical research proposals need not be pre-approved by institutional IRB, but should include a Human Studies section that addresses concerns pertaining to risk, benefit and consent (not included in the five page limit);
Revised applications should include an Introduction of not more than one page that describes how the applicant has responded to the reviewers’ criticisms.
Review & Decisions
Proposals received within the specified time frame are reviewed by the PSG Mentoring Committee. Applicants will be notified of the results on Monday, March 3, 2014. Funding will begin on July 1 and continue until June 30.
Successful applicants will be required to submit a short written summary of progress at six months and at one year after funding and attend the annual PSG meeting to present the results of the research done during their fellowship year. The meeting expense will be supported by the PSG separately from the grant award.
Parkinson's Disease Foundation Summer Student Fellowships
Applications due: Monday, January 27, 2014
PDF’s Summer Fellowship Program is used to support students – from advanced undergraduates to graduate and medical students – in their pursuit of Parkinson's-related summer research projects. The goal of the Summer Fellowship is to cultivate an early interest in Fellows into the cause and possible treatments for Parkinson's disease.
Fellows work under the close supervision of a sponsor who is an expert in the Parkinson's community and oversees the project. Typically, summer fellowships are offered for 10 weeks of clinical or laboratory work with an award of $4,000.
The award is to be used to support the student's summer research, for example, to defray tuition costs of research credits or to supplement living/housing costs. This award may taxable; an IRS form 1099 will be sent to the recipient at the end of the calendar year.
Undergraduate students, graduate students and medical students are all eligible for summer fellowships. Each applicant must identify a mentor with whom he or she will conduct the proposed project. This program is open to both national and international applicants.
Please note that this year, all applications must be submitted online through the PDF website at grants.pdf.org; no paper copies will be accepted. This application period typically opens in December closes at the end of January. Successful applicants are typically notified in mid-April of PDF's decisions.
Briefly, a complete application will consist of the following five items:
Brief, two-page proposal describing the research plan (written by applicant in conjunction with mentor);
Copy of the student’s academic transcript (unofficial is acceptable);
Statement by the applicant, describing why he or she is interested in conducting Parkinson's research, his or her qualifications, and the relevance of this research to his or her career/research interests;
Letter of support, written by the mentor under whom the applicant plans to work, discussing qualifications of the student, affirming that facilities and materials will be available and agreeing to actively guide the student’s work. This letter must be sent separately by the mentor either via email to firstname.lastname@example.org with “SUMMER FELLOWSHIP” in the subject line or via regular mail to Parkinson’s Disease Foundation; Summer Fellowship Letter of Support; Attn: Dr. Beth Vernaleo, Grants Manager; 1359 Broadway, Suite 1509, New York, NY 10018.
All letters must be received by the application deadline.;
Application form, completed.
Note: Incorrect or incomplete applications will be rejected without comment.
Applications are judged based on the feasibility of the applicant's project, the background of the applicant and the appropriateness of the mentor. Final decisions are typically made in mid-April. PDF will contact all candidates at that time. Funding for successful applicants may commence as early as June 1.
Parkinson Study Group Mentored Clinical Research Award for New Investigators in Patient-Oriented Research in Parkinson’s Disease and Related Disorders
The Mentored Clinical Research Award (MCRA) for new investigators is funded by a grant from the Parkinson’s Disease Foundation (PDF) to the Parkinson Study Group (PSG). The purpose of this grant is to support a new investigator for a 1 year project in patient oriented research in Parkinsons disease or other parkinsonian disorders under the mentorship of an experienced investigator. The goal of the Award is to provide funding for an investigator with the potential to become an independent researcher. Appropriate applicants for the MCRA are clinicians and scientists who are within 5 years of having completed formal training. The applicant must identify an appropriate mentor or mentors with extensive research experience. Either the applicant or the mentor must be a member of the PSG.
Application deadline: Friday, January 3, 2014
Award available: $50,000
Notification of award: March 3, 2014
Progressive MS Alliance Challenge Awards and Infrastructure Awards
Deadline - January 31, 2014
The Progressive MS Alliance (previously known as the International Progressive MS Collaborative) is working together to find answers and develop solutions to end progressive MS. The Alliance aims to build upon current research efforts and connect resources and experts around the world. The Alliance is pleased to announce two new funding initiatives designed to accelerate research focused on progressive MS.
1) Challenge Awards -These are designed to encourage and nurture scientific innovation in the following focus areas:
-- Phenotype/Genotype and pathophysiological mechanisms of progressive MS
-- Development of new and existing pre-clinical models for progressive disease based on community consensus building
-- Discovery and validation of proof of concept biomarkers
-- Innovative designs for proof of concept trials of therapeutic agents or therapeutic strategies
2) Infrastructure Awards -These are designed to promote and enhance data sharing and knowledge management and encourage collaboration among researchers by developing enabling technologies and infrastructure for data sharing to support one or more of the Alliance priority research areas.
Support for each of these awards is limited to a maximum of €75,000 in total costs for 12 months. This request for applications (RFA) is open to all international researchers in academic and other non-profit organizations, as well as to researchers in commercial organizations.
The application deadline is January 31, 2014. Details on how to apply for funding can be found at http://www.endprogressivems.org.
To learn more about the Progressive MS Alliance please visit our web site, www.endprogressivems.org.
We are looking forward to innovative proposals from around the world and from all disciplines. If you have an innovative idea or concept, please apply.
Michael J. Fox Foundation for Parkinson's Research Target Validation Program
Fall 2014 Review Cycle
Informational Conference Call*: March 26, 2014 at 12pm US ET
Pre-proposals Due: May 28, 2014 – 6pm US ET
Full Proposal Invitations: June 18, 2014
Full Proposals Due (by invite only): August 6, 2014 – 6pm US ET
Anticipated Award Announcement: October 2014
Anticipated Funding: November 2014
*MJFF will hold a 45-minute conference call on the dates and times listed above to clarify and explain the goals of this funding initiative and answer applicant questions. To participate in the call and receive call-in details, please RSVP via email to email@example.com.
The Target Validation program supports work to determine whether manipulation of a defined biological target provides a disease-relevant beneficial outcome in a whole animal, mammalian model of PD. MJFF does not have any pre-conceived preferences for particular targets submitted to the Target Validation program. However, we recommend applicants consider the following:
The target should be clearly defined, such as:
A specific gene
A structural/functional feature of a protein (e.g., its enzymatic activity, protein conformation or ability to interact with other proteins)
Proposals seeking to manipulate global pathways without a clear target are not encouraged
Applicants may propose a variety of methods to manipulate a target, including but not limited to:
Use of pharmacological tools
Supporting data/explanation of the proposed pharmacological tool must be addressed in the body of the proposal.
Parameters that should be discussed include:
Selectivity for the target of interest
Pharmacokinetic/Pharmacodynamic measures that have been/will be assessed
Measures of target engagement
Use of biologic strategies such as:
Viral vector-mediated gene delivery, etc.
In Vivo Models
Applicants may also propose use of models appropriate for the target proposed including:
Previously established genetically engineered animal models including:
Knockout models where the target/gene of interest is deleted
Transgenic models whereby the target/gene of interest is over-expressed
Investigators should proposed to examine PD-relevant features or sensitivity to PD-associated factors during the course of their studies
Proposals may include intermediate tests using in vitro, ex vivo and/or model organisms (e.g., Drosophila, C. elegans) to optimize the ideal target manipulation strategy
These proposals must ultimately include within the grant funding period an evaluation of the target manipulation in a whole-animal mammalian model of PD
Note: The following types of proposals are not appropriate for the Target Validation program:
Proposals focused on new target identification and proposals testing cellular transplantation approaches.
Proposals seeking to generate new genetic (knockin, knockout, transgenic) models
Investigators seeking guidance to develop new models around their target are encouraged to contact firstname.lastname@example.org
Applicants seeking support for therapeutic development should submit to the Therapeutic Pipeline Program or contact MJFF research staff for guidance.
MJFF will commit up to $10 million to the Edmond J. Safra Core Programs for PD Research with the intention to support multiple awards. The Target Validation program supports two-year grants up to $250,000 total costs inclusive of both direct and indirect costs. The total annual direct costs cannot exceed $100,000. No more than 25% (Academic institutions) or 10% (for-profit organizations) of the direct costs may go to indirect costs.
Applications may be submitted by:
U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held,
U.S. and non-U.S. entities, public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.
Post-doctoral fellows are NOT eligible to apply as Principal Investigators to the Target Validation program.
Call for Nominations: Barancik Prize for Innovation in Multiple Sclerosis Research
The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality. This annual prize, made possible by the generosity of the Charles and Margery Barancik SO Foundation, is $100,000 to be used at the discretion of the recipient.
Criteria and Nominations
The goal of the prize is to recognize innovation in scientific research in the field of multiple sclerosis. Nominations must be submitted on behalf an individual, or team of individuals, by one or more colleagues or mentors. Self-nominations are not permitted. Nomination letters should include current institution and contact information of the nominee, and should address the nominee’s scientific accomplishments with an emphasis on citing the innovative and impactful aspects of the nominee’s work. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research
Nominees that exhibit these qualities will be invited to submit a final application that will include an interview by the selection committee.
Any investigator(s) active in MS research is eligible for the prize, and the nominee(s) may be from any institution or organization— public or private, government, as well as commercial entities. Nominees may also be at any stage of their professional career in MS research. There are no specific requirements for residency or citizenship. Nominees need not be current or past grantees of the National MS Society.
Nomination letters should be sent to email@example.com starting November 1, 2013 until the January 31, 2014 deadline to be considered for the 2014 prize. Notification of the recipient shall occur by June 2014 followed by a public announcement.
Walter G. McMillen Memorial Award for Parkinson’s Disease Research
The Walter G. McMillen Memorial award is designed to encourage graduate student’s interest in research on Parkinson’s disease.
Potential research topics that will be funded by this award include, but are not limited to:
The assessment and treatment of persons with Parkinson’s disease.
The impact of this diagnosis on family support systems (e.g., caregiver burden).
For the purposes of this award, the term "research" is broadly defined to include any scholarly endeavor, including but not limited to experiments, correlational studies, qualitative investigations, historical work, case studies, and evaluation research.
However, the focus of this research must be on the assessment, treatment, or management of Parkinson’s disease.
The cash award of $1,000 is intended to offset direct costs associated with the planned research. These may include salaries, equipment, supplies, stipends for study participants, etc.
Note that the monies will be awarded to the candidate’s institution and not directly to the applicant.
Indirect costs are not supported by this award. Candidates should contact their grants office to ensure that indirect costs can be waived prior to applying for this award.
Annual deadline: March 15
The award competition is open to doctoral-level graduate students.
Only one submission per student will be reviewed each year.
The funded research proposal is expected to be conducted during the next academic year.
To be eligible for this award, the student must initiate and conduct the project under the supervision of a professor or research advisor. The applicant is expected to be the principal investigator on the project.
How to Apply
Research proposals should include:
An abstract (up to 400 words)
A research plan (not to exceed five pages using 12-point font or larger), including:
• Specific aims/hypotheses
• Background and significance
• Research design and methods
• How the grant funds will be used
• Cited literature
Applicants must also submit:
A biographical sketch (not to exceed one page), that includes in list format:
• Schools attended with degrees attained
• Relevant professional position
• Society memberships
• Publications and/or paper presentations
• Relevant coursework
• Any other relevant information you would like to include
A short supporting statement by the faculty sponsor verifying the nature of and the relative contribution to the research by the student submitting the proposal. This statement should be short, not to exceed one paragraph, and emailed directly from the advisor.
Please submit applications electronically as an email attachment to the co-chair of the Awards Committee. Type "McMillen Award Submission" in the subject line of the email.
International Essential Tremor Foundation Grant Program
The IETF grant program provides funds to members of the scientific community who submit proposals that address the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor (ET).
The aim of program is to stimulate inquiry into this poorly understood clinical disorder and to provide support to projects that are innovative and give promise of receiving more substantial support from NIH, K Award, R01 and/or other sources if sufficient preliminary information can be obtained from projects supported by the IETF. Preference will be given to individuals who do not currently have any R01 support from NIH.
The IETF would very much like to encourage anyone interested to submit a proposal.
Proposals can be submitted between November 1 and February 28 each year. Questions regarding research funding or grant submission should be directed to Catherine Rice, Executive Director, at 913.341.3880 or email at firstname.lastname@example.org